Vector Science appoints Russell Starr as president

Vector Science & Therapeutics appointed Russell Starr as president, effective Oct. 5, 2026. Starr is a capital markets executive with experience in complex financings, strategic transactions, public listings, corporate development. Appointment adds a senior leadership role as the company targets its next growth phase in pharma-grade peptides. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202610140730CANADANWCANADAPR_C7418) on October 14, 2026, and is solely responsible for the information contained therein. (C)